GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

Adding to these challenges, if an effective drug were found, it would take many years to build up a sufficient evidence base and millions of dollars to bring it to market. For these reasons ...

The Trump administration made a decidedly pro-industry statement on the Inflation Reduction Act (IRA). In an executive order issued Tuesday, President Donald Trump outlined changes to the Biden ...

Germany's largest pharmaceutical company Boehringer Ingelheim on Wednesday reported a currency-adjusted 6.1% gain in 2024 revenues, buoyed by diabetes drug Jardiance and lung drug Ofev.

Established under President Joe Biden’s Inflation Reduction Act of 2022, the Medicare Drug Price Negotiation Program allows ...

Maryland lawmakers have expanded a state board’s authority to set statewide upper-payment limits on high-cost prescriptions.

India is home to more than 100 million diabetics, and the demand for anti-diabetic drugs is on the rise -- the Rs 20,611 crore anti-diabetic drug market in India is growing at 9 per cent or so.

If you ever find yourself doing outdoor hobbies in slow motion or bursting into a full-blown musical theater scene at the ...

The innovator drug named Jardiance by BI costs around Rs 60 per tablet. Delhi-based Mankind Pharma launched a range of empagliflozin products, including its combinations, priced between Rs 5.5 and ...

New research suggests that GLP-1 drugs like Ozempic and Wegovy, commonly used for diabetes and weight loss, may also reduce the risk of Alzheimer's disease and dementia.